User:Choonab: Difference between revisions

Content deleted Content added

Inline

Revision as of 12:53, 7 January 2022

Efficacy and safety of novel herbal tablets in COVID-19 patients in hospital stay days, ICU admission and mortality rate thereof: An open-label, single-blind randomized clinical trial <ref>https://brief.land/jjnpp/articles/117677.html

Revision as of 12:52, 7 January 2022 edit Choonab (talk \| contribs) 24 edits Efficacy and safety of novel herbal tablets in COVID-19 patients in hospital stay days, ICU admission and mortality rate thereof: An open-label, single-blind randomized clinical trial Tags: Mobile edit Mobile web edit		Revision as of 12:53, 7 January 2022 edit undo Choonab (talk \| contribs) 24 edits No edit summary Tags: Mobile edit Mobile web edit Next edit →
Line 1:		Line 1:
	Efficacy and safety of novel herbal tablets in COVID-19 patients in hospital stay days, ICU admission and mortality rate thereof: An open-label, single-blind randomized clinical trial		Efficacy and safety of novel herbal tablets in COVID-19 patients in hospital stay days, ICU admission and mortality rate thereof: An open-label, single-blind randomized clinical trial <ref>https://brief.land/jjnpp/articles/117677.html